Role of 18F-PET/CT in Predicting Prognosis of Patients With Breast Cancer After Neoadjuvant Chemotherapy

The general rules for clinical and pathological recording of breast cancer

Surgery Today · 1989 · 377 citations

Medicine, Oncology, Pathology +16

Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy

Viviana Londero, Massimo Bazzocchi, Chiara Del Frate et al. · European Radiology · 2004 · 232 citations

Medicine, Oncology, Radiology +17

18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques

Bas B. Koolen, Marie-Jeanne T. F. D. Vrancken Peeters, Tjeerd S. Aukema et al. · Breast Cancer Research and Treatment · 2011 · 148 citations

Medicine, Oncology, Radiology +17

Use of [18F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [18F]-FDG PET-predicted non-responders (AVATAXHER): an open-label, randomised phase 2 trial

Bruno Coudert, Jean‐Yves Pierga, Marie‐Ange Mouret‐Reynier et al. · The Lancet Oncology · 2014 · 142 citations

Medicine, Oncology, Breast Oncology +15

Clinical and Radiologic Assessments to Predict Breast Cancer Pathologic Complete Response to Neoadjuvant Chemotherapy

Anne F. Schott, Marilyn A. Roubidoux, Mark A. Helvie et al. · Breast Cancer Research and Treatment · 2005 · 142 citations · Full text

Medicine, Oncology, Radiology +14